LLY

745.65

-0.79%↓

JNJ

148.78

-3.72%↓

UNH

319.44

-15.48%↓

ABBV

188.31

-1.36%↓

ABT

129.75

-2.06%↓

LLY

745.65

-0.79%↓

JNJ

148.78

-3.72%↓

UNH

319.44

-15.48%↓

ABBV

188.31

-1.36%↓

ABT

129.75

-2.06%↓

LLY

745.65

-0.79%↓

JNJ

148.78

-3.72%↓

UNH

319.44

-15.48%↓

ABBV

188.31

-1.36%↓

ABT

129.75

-2.06%↓

LLY

745.65

-0.79%↓

JNJ

148.78

-3.72%↓

UNH

319.44

-15.48%↓

ABBV

188.31

-1.36%↓

ABT

129.75

-2.06%↓

LLY

745.65

-0.79%↓

JNJ

148.78

-3.72%↓

UNH

319.44

-15.48%↓

ABBV

188.31

-1.36%↓

ABT

129.75

-2.06%↓

Search

Dynavax Technologies Corp

Ouvert

SecteurSoins de santé

9.71 -0.31

Résumé

Variation du prix de l'action

24h

Actuel

Min

9.51

Max

10.16

Chiffres clés

By Trading Economics

Revenu

-11M

7.1M

Ventes

-8.6M

72M

P/E

Moyenne du Secteur

58.75

54.379

BPA

0.05

Marge bénéficiaire

9.787

Employés

405

EBITDA

1.3M

11M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+157.7% upside

Dividendes

By Dow Jones

Prochains Résultats

5 août 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-277M

1.4B

Ouverture précédente

10.02

Clôture précédente

9.71

Sentiment de l'Actualité

By Acuity

40%

60%

143 / 382 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Very Strong Bearish Evidence

Dynavax Technologies Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

12 mai 2025, 22:34 UTC

Acquisitions, Fusions, Rachats

Ampol to Sell Retail Electricity Businesses in Australia, New Zealand

12 mai 2025, 23:48 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

12 mai 2025, 23:46 UTC

Market Talk

Nikkei Likely to Rise on Hopes for Improving U.S.-China Trade Relations -- Market Talk

12 mai 2025, 23:34 UTC

Market Talk

Trade Deal Lowers US Recession Risks to 35% -- Market Talk

12 mai 2025, 23:21 UTC

Market Talk

US-China Trade Deal Still Risks Stagflation; Supply Chain Disruption -- Market Talk

12 mai 2025, 22:54 UTC

Market Talk

Australian Treasurer Warns Uncertainty Will Still Dominate Markets -- Market Talk

12 mai 2025, 22:43 UTC

Résultats

Telefonica Brasil 1Q EPS BRL0.65 >VIV

12 mai 2025, 22:14 UTC

Actualités

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- 2nd Update

12 mai 2025, 22:08 UTC

Acquisitions, Fusions, Rachats

Ampol Expects Replacement-Cost Ebitda Uplift by Run Rate at End-2025 of Around A$30 Million/Year

12 mai 2025, 22:08 UTC

Acquisitions, Fusions, Rachats

Ampol Expects Pretax Proceeds of Around A$65 Million From Transactions

12 mai 2025, 22:07 UTC

Acquisitions, Fusions, Rachats

Ampol to Sell Australia Retail Electricity Business for Nominal Sum

12 mai 2025, 22:07 UTC

Acquisitions, Fusions, Rachats

Ampol to Sell Australia Retail Electricity Business to AGL

12 mai 2025, 22:06 UTC

Acquisitions, Fusions, Rachats

Meridian to Take on Flick, Z Energy Branded Electricity Customers

12 mai 2025, 22:06 UTC

Acquisitions, Fusions, Rachats

Meridian Energy to Buy Business From Ampol for NZ$70 Million

12 mai 2025, 22:05 UTC

Acquisitions, Fusions, Rachats

Ampol to Sell New Zealand Electricity Retailing Businesses to Meridian Energy

12 mai 2025, 22:04 UTC

Acquisitions, Fusions, Rachats

Ampol to Sell Retail Electricity Businesses in Australia, New Zealand

12 mai 2025, 21:15 UTC

Actualités

Republican Tax Plan Boosts SALT Deduction, Ends Green-Energy Breaks -- 2nd update -- WSJ

12 mai 2025, 21:01 UTC

Résultats

Constellation Software 1Q Rev $2.65B >CSU.T

12 mai 2025, 21:01 UTC

Résultats

Constellation Software 1Q Net $115M >CSU.T

12 mai 2025, 21:01 UTC

Résultats

Constellation Software 1Q EPS $5.44 >CSU.T

12 mai 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

12 mai 2025, 20:50 UTC

Market Talk
Résultats

Basic Materials Roundup: Market Talk

12 mai 2025, 20:44 UTC

Actualités

Trade Thaw Sparks Stock Rally, Leaves Wall Street Cautious -- WSJ

12 mai 2025, 20:31 UTC

Actualités

How to Think About the Stock Market When Earnings Guidance Becomes Meaningless -- Heard on the Street -- UPDATED -- WSJ

12 mai 2025, 20:24 UTC

Résultats

Energy Vault Holdings: Encouraging News on China/U.S. Tariff Pause, Pending Final Positive Resolution and Timing >NRGV

12 mai 2025, 20:24 UTC

Résultats

Energy Vault Holdings: No Change to Current Guidance, With Potential Rev Upside on Accelerated U.S. Battery Deliveries in 2025 >NRGV

12 mai 2025, 20:24 UTC

Actualités

Republican Tax Plan Boosts SALT Deduction, Ends Green-Energy Breaks -- WSJ

12 mai 2025, 20:22 UTC

Acquisitions, Fusions, Rachats

Spirit AeroSystems Holdings: IRS Rules That Sale to Boeing Will Qualify as a Reorganization Under Section 368(a)(1)(B)

12 mai 2025, 20:15 UTC

Résultats

Rigetti Computing Reports Earnings. How the Company Takes a Different Approach to Quantum. -- Barrons.com

12 mai 2025, 20:10 UTC

Résultats

Blink Charging 1Q Rev $20.8M >BLNK

Comparaison

Variation de prix

Dynavax Technologies Corp prévision

Objectif de Prix

By TipRanks

157.7% hausse

Prévisions sur 12 Mois

Moyen 24.25 USD  157.7%

Haut 31 USD

Bas 10 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

5 ratings

4

Achat

0

Maintien

1

Vente

Score Technique

By Trading Central

9.62 / 10.9Support & Résistance

Court Terme

Very Strong Bearish Evidence

Moyen Terme

Very Strong Bearish Evidence

Long Terme

Strong Bearish Evidence

Sentiment

By Acuity

143 / 382Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Dynavax Technologies Corp

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.